期刊名称:TRANSPLANT INTERNATIONAL
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Transplant International
The journal serves as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Both full-length articles and short papers are included in the journal. Publishing time for the latter is approximately six months, provided major revisions are not needed. The journal is published in yearly volumes, each volume containing twelve issues. Papers submitted to the journal are subject to peer review.
"Transplant International" is the official journal of the European Society for Organ Transplantation (ESOT) and the European Liver Transplant Association (ELTA).
![Transplant International - Cover](http://www.wiley.com/bw/content/BPL_Images/Journal_cover_store/thumbnail/TRI-0934-0874-21-1/tri.jpg)
Instructions to Authors Author Guidelines
Transplant International
Official journal of the European Society for Organ Transplantation, the European Liver and Intestive Transplant Association and the German Transplantation Society (Deutsche Transplantationsgesellschaft, DTG)
Edited by: Ferdinand Mühlbacher and Thomas Wekerle
Print ISSN: 0934-0874 Online ISSN: 1432-2277 Frequency: Monthly Current Volume: 21/2008 ISI Journal Citation Reports®Ranking: 2006: 30/138 (Surgery); 11/19 (Transplantation) Impact Factor: 2.146
AUTHOR GUIDELINES (Click here for PDF version)
Editorial policies and procedures Authorship Ethics Clinical Trials Exclusive Licence to Publish OnlineOpen Submission of papers Electronic File Formats Manuscript preparation Manuscript types Review Articles Original Articles Case Reports Letters to the Editor Invited Commentary Manuscript Format & Layout Title Page Abstract Keywords Abbreviations Text References Tables Figures Accepted Papers Proofs Offprints Ealry View
Authors Services Author material archive policy Disclaimer
Editorial policies and procedures
Transplant International is the official journal of the European Society for Organ Transplantation (ESOT), the European Liver and Intestine Transplant Association (ELITA) and the German Transplantation Society (Deutsche Transplantationsgesellschaft, DTG). It provides a forum for the publication of clinical and experimental research on the biology, physiology, and immunology of tissue and organ transplantation. The journal is published in print and online in yearly volumes, twelve times a year.
Transplant International will not consider manuscripts that have been published previously or that are under consideration for publication eleswhere.
Manuscripts will be peer-reviewed. At the discretion of the Editors, the submitted manuscript may be rejected immediately, without full review, for instance if it falls outside of the field of transplantation or if it does not comply with international ethical standards (see below).
Authorship
All persons listed as authors must have contributed substantially to the design, performance, analysis, or reporting of the work and are required to indicate their specific contribution. The specific requirements for authorship have been defined by the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org). Examples of authors contributions are: "designed research/study"', "performed research/study", "contributed important reagents", "collected data", "analyzed data", "wrote paper" etc. This information must be included in the title page of the manuscript and will be printed if the paper is accepted for publication. The corresponding author is responsible for obtaining permission from all co-authors for the submission of any version of the manuscript and for any changes in authorship.
Ethics
Manuscripts must contain a statement to the effect that all human studies have been reveiwed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 2000 Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm). It should also be state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted.
Reports of animal experiments must state that the "Principles of Laboratory animal care" NIH publication Vol 25, No. 28 revised 1996; http://grants.nih.gov/grants/guide/noticefiles/not96-208.html) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
Clincal Trials
Transplant International will only consider publishing trials that have been registered in a public trials registry. The name of the registry and the registration number should be stated at the end of the abstract of the manuscript. Trials must register at or before patients are enrolled. This policy applies to any clinical trial starting enrolment of subjects after January 1, 2006. Trials that began enrolment before January 1, 2006 are required to register by April 1, 2006. We define clinical trials according to ICMJE, as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause and effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase I trials), would be exempt.
Click here to view 2005 editorial, "Transplant International adopts the policy of a uniform clinical trial registration".
Registration must be done at a registry that meets the following minimum criteria:
- Accessible to the public at no charge.
- Searchable by standard electronic (internet-based) methods.
- Open to all prospective registants free of charge or at minimal cost.
- Validates registered information.
- Identifies trials with a unique number.
- Included information on: the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed), and funding source(s).
Registries that currently meet these criteria include:
- The registry sponsored by the U.S. National Library of Medicine (www.clinicaltrials.gov).
- The International Standard Randomised Controlled Trail Number Registry (www.controlled-trials.com).
- The Cochrane Renal Group registry (www.cochrane-renal.org/trialsubmissionform.php).
- The National (U.K.) Research Register (www.update-software.com/national)
- Euporean Clinical Trials Database (http://eudract.emea.eu.int/)
The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above mentioned requirements.
Exclusive Licence to Publish All submitted manuscripts must be accompanied by either a completed Exclusive Licence Form: http://www.blackwellpublishing.com/pdf/elf_tri.pdf or a completed Online Open Exclusive Licence Form (see below), faxed and mailed to the Editorial Office: Fax +43 140400 6767.
Transplant International Vienna General Hospital Division of Transplantation Ebene 9.D5.18 Währinger Gürtel 18-20 A-1090 Vienna Austria
The work shall not be published elsewhere in any language without the written consent of the publisher. The articles published in this journal are protected by the licence, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm or videocassettes or in electronic databases and the like or reproduced photographically without the prior written permission of the publisher.
Online Open
Online Open is a pay-to-publish service that offers authors whose papers are accepted for publication the opportunity to pay up-front for their manuscripts to become open access (i.e. free for all to view and download). Each Online Open article will be subject to a one-off fee of $3000 to be met by or on behalf of the author in advance of publication. Upon online publication, the article (both full-text and PDF versions) will be available to all for viewing and download free of charge. The print version of the article will also be branded as Online Open and will draw attention to the fact that the paper can be downloaded for free. Any author wishing to send their paper Online Open should complete the Online Open Exlusive Licence Form. Please note that this form is for use with Online Open material ONLY. Prior to acceptance there is no requirement to inform the Editorial Office that you intend to publish your paper Online Open if you do not wish to do so.
Submission of papers Only electronic submissions will be considered. Please submitt your paper online ScholarOne Manuscripts (formerly known as Manuscript Central) Http://mc.manuscriptcentral.com/tri
The Editorial Office will acknowledge receipt of all manuscripts. If the manuscript submission is incomplete or does not conform to the Author Guidelines, it will be un-submitted. The corresponding author will then be asked to complete and re-submit the manuscript.
Electronic File Formats Manuscript text must be saved in Word (.doc) Wordperfect (.wpd) or Rich text Format (.rtf) as our publisher requires this formatting in the event of acceptance. Do not submit text that is already in PDF format.
Please note that Word 2007 is not yet compatible with our journal's production systems. Unfortunately, we cannot accept Microsoft Word 2007 documents until such time as a stable production version is released. Please use Word's 'Save As' option to save your document as an older (.doc) file type.
Figures may be submitted in any of the following formats: Word (.doc) Wordperfect (.wpd) or Rich text Format (.rtf) Jpeg (.jpg) GIF (.gif) TIFF (.tiff) Powerpoint (.ppt) and Bitmap (.bmp). NOTE: Figures submitted in Portable Document Format (.pdf) must be distilled using the "Print Optimised" option.
Manuscript preparation
Authors should prepare manuscripts in accordance with: "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (http://www.ICMJE.org). Authors are responsible for linguistic and grammatical editing of manuscripts before submission to the Journal. Manuscripts improperly prepared or edited will be returned to the authors without review by the Editors. Non-English-speaking authors should have their papers checked for linguistic accuracy by a native English speaker.
Terminology: Use of words such as "cadaveric", "retrieval" and "harvesting" when describing deceased donors is not accepted. Please refer to the following list when referring to such donors:
PLEASE USE: |
INSTEAD OF: |
recover or recovery of organs |
harvest or retrieval |
deceased donor |
cadaver, cadaveric |
mechanical, ventilated or organ-perfusion support |
life support |
donation after cardiac death |
non-heart-beating donation |
Manuscript types
Review Articles Word Limit: 4000 words including abstract but excluding references, tables and figures. Abstract: 200 words maximum References: No limit
Reviews of special interest in the field of transplantation are solicited by the Editor-in-Chief and Co-Editor-in-Chief. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited Review Articles will undergo peer review prior to acceptance. The approach of review articles should be critical but balanced. No submitted manuscripts or personal communications should be cited. It is the responsibility of authors to obtain permission from the copyright holder of any figure they wish to have republished and they are required to provide a confirmation thereof.
Original Articles Word Limit: 4000 words including abstract but excluding references, tables and figures. Abstract: 200 words maximum References: No limit Full length reports of current research in either experimental or clinical transplantation.
Case Reports Word Limit: 1500 words including abstract but excluding references, tables and figures. Abstract: 150 words maximum References: Up to 20 Only cases of exceptional interest and novelty will be considered together with an overview and discussion of relevant literature. Due to this strict policy, the rejection rate of Case Reports is approximately 90%.
Letters to the Editor
Word Limit: 500 words excluding references, tables and figures.
No abstract, no headings or subheadings.
References: Up to 15.
Limit of one table or one figure.
Observations on critical topics in transplantation or comments on articles published in Transplant International.
Invited Commentary Word Limit: 1000 words excluding references, tables and figures. No abstract required for this manuscript type References: Up to 15 Comments with critical assessment of papers recently accepted or published in Transplant International.
Manuscript Format & Layout
- Title page
-
Abstract
-
Keywords
-
Abbreviations
-
Text
-
References
-
Tables
-
Figures
Title Page Must contain the following:
-
Title not to exceed 30 words
-
Full names of all authors. Authors should be limited to those individuals who contributed in an important manner to the study design, data, collection and analysis, or writing of the paper.
-
Department and Institution where work was performed clearly noting the affiliations of the individual authors.
-
Authorship. Please list a description of each author's contribution or role, e.g. "designed research/study", "performed research/study", "contributed important reagents", "collected data", "analyzed data", "wrote the paper " etc.
-
Funding sources. Authors must disclose any conflicts of interest that might bias their work. All funding sources supporting the work sumbitted should be properly acknowledged and stated in the title page. Authors are expected to disclose any commercial associations that might pose a conflict of interest in connection with the submitted manuscript.
-
Corresponding author contact information. Name, address, telephone, FAX, and E-mail address of the author to whom correspondence regarding the manuscript should be directed.
-
Running Title. A shortened version of the title that is 70 characters or less to be used in the page header upon publication.
Abstract Not more than 200 words without the subheading, stating the main problem, methods, results, and conclusions. For clinical trials, the name of the registry and the registration number should be stated at the end of the abstract in parentheses, for example: (ClinicalTrials.gov number: NCT00365846).
Keywords A maximum of 6 keywords, arranged alphabetically.
Abbreviations When using abbreviations, write the full name of the abbreviated item folled by the abbreviation in parenthesis at the point of first mention of the abbreviation in within the body of the manuscript: e.g. "according to the policies of the United Network for Organ Sharing (UNOS)."
Text Arranged in the following order: Introduction, Patients and Methods (or Materials and Methods), Results, Discussion, Acknowledgements. It is essential that the positions of figures and tables are identical in the margins of the text.
References Referencing should be listed in order of appearance (straight Vancouver style). Feasible reference managers are offered by many leading scientific publications such, as J Intern Med.
1. All references must be designed within the text by full-sized numbers in ascending order within square brackets.
2. The reference list should contain the references in the order in which they are cited in the text.
3. Only published works (as well as manuscripts already accepted for publication) which are referred to in the text should be listed in the reference list. The reference list must not contain any unpublished observations, personal communications, etc. Kindly cite such sources solely within the text (in parentheses), not in the reference list.
4. Do not list more than six authors per reference. Should there be seven or more, please include only the first three followed by ''et al.''.
5. Please style your references according to the following examples (please note sequence, punctuation, and spacing):
-
Journal articles: name(s) and initials of author(s), full title, journal name as abbreviated in Index Medicus, year of publication; volume, page number. e.g.: Bock HP, Sombolos V, Lucas PA, et al. Complications of gastric surgery in transplanted Patients. J Transplant Surg 1987; 38: 213.
-
Monographs: name(s) and initials if author(s), title, edition, publisher, place of publication, year of publication, page number. e.g.: Kay PJ. Graft versus host disease, 2nd edn. Springer, Berlin, 1978; 11.
-
Contribution within edited works: name(s) and initials of author(s), title of the contribution, ''In:'', name(s) and initials of editor(s), title of the book, publisher, place of publication, year of publication, page number. e.g.: Feldman SP. The role of leucocytes in rejection. In: Dragon S, Curius P, Velasques RC, eds. The process of rejection. The Hague, Nijhof, 1996: 38.
Tables
Each table should be numbered consecutively with Arabic numerals and should be cited in the text. A descriptive heading which is self-explanatory should be included. Footnotes to tables should be indicated by lower-case superscript letters and should be kept to a minimum.
Figures All figures should be cited in the text in numerical order. Figures should clarify the text and be kept to a minimum. The same results should be presented as either graphs or tables, not as both. Original colour transparencies should be labelled on the back with the number, first author's name, and should indicate the top of the figure. If photographs of patients are used, either the subject should not be identifiable or the picture must be accompanied by wirtten permission to use the figure. Figure legends must be typed on a separare page at the end of the manuscript. Figures should be professionally drafted, and the halftones should exhibit high contrast. Details must be large enough to retain their clarity after reduction in size. After reduction, illustrations should preferably fill single-column width (81 mm) although in exceptional cases 2/3 page width (120 mm) or full-page width (168 mm) will be accepted.
Colour Figures Authors are required to pay for any colour illustrations for the print publication of the journal. Colour figures may be published for free in the online version of the article, i.e. free colour-on-the-web (CoW) service.
If you are willing to pay for the colour figrues for the print publication you must complete and return a colour work agreement form before your paper can be published. This form is a PDF* file. To read PDF files, you must have Acrobat Reader installed on your computer. If you do not have this program, this is available as a free download from the following web address: http://www.adobe.com/products/acrobat/readstep2.html If you are unable to download the form, please contact the Editorial office.
Once completed, please return the form to the Production Editor at the address below:
Barbara Fitzsimons, Production Editor Wiley-Blackwell, John Wiley & Sons 101 George Street Edinburgh EH2 3ES, UK Fax: +44 (0) 131 226 3803 Email: barbara.fitzsimons@wiley.com
Please note, if you have chosen this option, your article will not be published until the Production Editor has received your colour work agreement form.
If you are not willing to cover the costs of reproducing colour figures in print, your figures may be published in colour for free in the online version of the article (but they will still appear in black and white in the print version). If you wish to take advantage of this free colour-on-the-web (CoW) service, please ensure that the figures are suitable for both colour and black and white reproduction. If you have any questions, please contact the Production Editor.
Accepted papers
Proofs
Proofs will be sent via e-mail as an Acrobat PDF (portable document format) file. Please return proofs to the Production Editor within 72 hours, or you will risk delaying the publication of your article.
Offprints
Corresponding authors will automatically receive a free PDF offprint by e-mail. Additional offprints can be ordered on the offprint order form, which accompanies the proofs.
Early View
Transplant International is covered by the Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles mean that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continued to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html
Author Services Online production tracking is available for your article through Author Services Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit www.blackwellpublishing.com/bauthor for more detials on online production tracking and a for a wealth of resources including FAQs and tips on article preparation, submission and more.
Author material archive policy
Please note that unless specifically requested, the Publisher will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible if you have not yet done so.
Disclaimer
The Publisher, Societies and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal, the views and opinions expressed do not necessarily reflect those of the Publisher, Societies and the Editors, neither does the publication of advertisements constitute any endorsement by the Publisher, Societies and Editors of the products advertised.
Instructions to Authors 0934-0874.pdf .pdf
Editorial Board
Editorial Information
Editor-In-Chief Ferdinand Muhlbacher, Vienna
Co-Editor-In-Chief Thomas Wekerle, Vienna
Associate Editors David Adams, Birmingham Leo Bühler, Geneva Patrizio Burra, Padua Diego Cantarovich, Nantes Uwe Heemann, Munich Rainer Oberbauer, Vienna Johann Pratschke, Berlin Wojtek Rowinski, Warsaw Stefan G. Tullius, Boston
Assistants To The Editors Milene Wirth Fernandez, Vienna Liz Hablit, Vienna Martin Meyrath, Vienna
Editorial Office Transplant International Vienna General Hospital Division of Transplantation Ebene 9.D5.18 Währinger Gürtel 18-20 A-1090 Vienna Austria T: (+43) 1 40 400 6874 F: (+43) 1 40 400 6767 transpl-int@meduniwien.ac.at
Editorial Board G. Berlakovich, Vienna T. Carrel, Berne H. Ekberg, Malm?BR>J. Fabre, London C. Fourtounas, Patras P. Friend, Oxford J.M. Griny? Barcelona R. Gruessner, Minneapolis B. Krämer, Regensburg J. Langrehr, Berlin R. Margreiter, Innsbruck M. J. Mihatsch, Basel E. Möller, Huddinge M. Olausson, Göteborg G. Opelz, Heidelberg S. Paraskevas, Montreal M. Pascual, Lausanne P. Pfeffer, Oslo M. Soares, Oeiras J-P. Soulillou, Nantes J. P. Squifflet, Brussels J. F. Teixeira, Porto J. Wallwork, Cambridge K. Wood, Oxford
International Advisory Board G. Böhmig, Vienna F. H. J. Claas, Leiden B-G. Ericzon, Huddinge D. Grant, Toronto A. Haverich, Hannover K. Höckerstedt, Helsinki H. Kreis, Paris C. Legendre, Paris I. Marzi, Frankfurt F. Mosimann, Fleurimont, Québec P. Neuhaus, Berlin C. Ponticelli, Milan R. H. Rubin, Cambridge, MA M. Säemann, Vienna M. J. H. Slooff, Groningen H. W. Sollinger, Madison, WI W. J. van Son, Groningen S. Stewart, Cambrige Y. Vanrenterghem, Leuven D. White, London, ON Y. Yamaoka, Osaka
|